The novel coronavirus emerged last year in China’s Wuhan province. A fourth COVID-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June. In an interview with state TV on Monday, CDC chief biosafety expert Guizhen Wu said that China has four experimental vaccines in the third and final stage of clinical trials. She added that phase 3 clinical trials were proceeding smoothly and the vaccines could be ready for the general public in November or December. A unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and US-listed Sinovac Biotech are developing the three vaccines under the state’s emergency use programme. COVID-19 vaccines being developed in China may be ready for use by the general public as early as November, the Chinese Center for Disease Control and Prevention (CDC) said. It has killed more than 925,000 people. Wu also said that she took an experimental vaccine herself in April, and that she has experienced no abnormal symptoms.
EPA-EFE/ROMAN PILIPEY style=”font-size:40px; line-height: 1.3em; font-weight: 800; padding:7px;”>China coronavirus vaccine may be ready for public in November
By Elena Pavlovska
epa08628350 A Sinovac company logo is displayed at the company’s headquarters in Beijing, China, 26 August 2020 (issued 27 August 2020). Chinese company Sinovac Biotech is developing the COVID-19 vaccine candidate called CoronaVac. EPA-EFE/ROMAN PILIPEY
A Sinovac company logo is displayed at the company's headquarters in Beijing, China, 26 August 2020 (issued 27 August 2020). Chinese company Sinovac Biotech is developing the COVID-19 vaccine candidate called CoronaVac.